Zanubrutinib

Gilead loses patent case to Bristol-Myers over its CAR-T therapy; Amneal beats Dr. Reddy’s on key generic approval

This week, Phispers brings you news on Bristol-Myers Squibb winning a patent case against Gilead’s Yescarta — a US$...

Impressions : 1959

Teva, Endo may go bankrupt in a year, says study; Novartis buys The Medicines Company for US$ 9.7 billion

This week, Phispers has news of a study that identifies 31 troubled biopharma companies that are at very high risk of going ban...

Impressions : 7746